Literature DB >> 8898221

PAR-2 is asymmetrically distributed and promotes association of P granules and PAR-1 with the cortex in C. elegans embryos.

L Boyd1, S Guo, D Levitan, D T Stinchcomb, K J Kemphues.   

Abstract

The par genes participate in the process of establishing cellular asymmetries during the first cell cycle of Caenorhabditis elegans development. The par-2 gene is required for the unequal first cleavage and for asymmetries in cell cycle length and spindle orientation in the two resulting daughter cells. We have found that the PAR-2 protein is present in adult gonads and early embryos. In gonads, the protein is uniformly distributed at the cell cortex, and this subcellular localization depends on microfilaments. In the one-cell embryo, PAR-2 is localized to the posterior cortex and is partitioned into the posterior daughter, P1, at the first cleavage. PAR-2 exhibits a similar asymmetric cortical localization in P1, P2, and P3, the asymmetrically dividing blastomeres of germ line lineage. This distribution in embryos is very similar to that of PAR-1 protein. By analyzing the distribution of the PAR-2 protein in various par mutant backgrounds we found that proper asymmetric distribution of PAR-2 depends upon par-3 activity but not upon par-1 or par-4. par-2 activity is required for proper cortical localization of PAR-1 and this effect requires wild-type par-3 gene activity. We also find that, although par-2 activity is not required for posterior localization of P granules at the one-cell stage, it is required for proper cortical association of P granules in P1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898221     DOI: 10.1242/dev.122.10.3075

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  88 in total

Review 1.  The beginning of the end.

Authors:  D St Johnston
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  Polarization of the C. elegans zygote proceeds via distinct establishment and maintenance phases.

Authors:  Adrian A Cuenca; Aaron Schetter; Donato Aceto; Kenneth Kemphues; Geraldine Seydoux
Journal:  Development       Date:  2003-04       Impact factor: 6.868

3.  An intimate look at LET-23 EGFR trafficking in the vulval cells of live C. elegans larvae.

Authors:  Juan M Escobar-Restrepo; Alex Hajnal
Journal:  Worm       Date:  2014-10-30

4.  Stabilization of cell polarity by the C. elegans RING protein PAR-2.

Authors:  Yingsong Hao; Lynn Boyd; Geraldine Seydoux
Journal:  Dev Cell       Date:  2006-02       Impact factor: 12.270

5.  Interaction of PAR-6 with CDC-42 is required for maintenance but not establishment of PAR asymmetry in C. elegans.

Authors:  Donato Aceto; Melissa Beers; Kenneth J Kemphues
Journal:  Dev Biol       Date:  2006-08-09       Impact factor: 3.582

6.  PAR-3 and PAR-1 inhibit LET-99 localization to generate a cortical band important for spindle positioning in Caenorhabditis elegans embryos.

Authors:  Jui-Ching Wu; Lesilee S Rose
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

7.  Probing single-cell micromechanics in vivo: the microrheology of C. elegans developing embryos.

Authors:  Brian R Daniels; Byron C Masi; Denis Wirtz
Journal:  Biophys J       Date:  2006-03-31       Impact factor: 4.033

Review 8.  Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer.

Authors:  Ralph A Neumüller; Juergen A Knoblich
Journal:  Genes Dev       Date:  2009-12-01       Impact factor: 11.361

9.  PAR-2, LGL-1 and the CDC-42 GAP CHIN-1 act in distinct pathways to maintain polarity in the C. elegans embryo.

Authors:  Alexander Beatty; Diane G Morton; Kenneth Kemphues
Journal:  Development       Date:  2013-03-27       Impact factor: 6.868

10.  NMY-2 maintains cellular asymmetry and cell boundaries, and promotes a SRC-dependent asymmetric cell division.

Authors:  Ji Liu; Lisa L Maduzia; Masaki Shirayama; Craig C Mello
Journal:  Dev Biol       Date:  2010-01-06       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.